Journal: Science Advances
Article Title: Pharmacologic HIF stabilization activates costimulatory receptor expression to increase antitumor efficacy of adoptive T cell therapy
doi: 10.1126/sciadv.adq2366
Figure Lengend Snippet: ( A to D ) Activated CD8 + T cells were expanded for 16 hours in the presence IL-2 +/- molidustat (MOL; 60 μM). 4-1BB (A), CD81 (B), GITR (C), or OX40 (D) mRNA was analyzed by RT-qPCR (mean +/- SEM, n = 3). * P < 0.05, **** P < 0.0001 versus vehicle (two-tailed Student’s t test).
Article Snippet: The cells were activated for 48 hours and then expansion medium containing recombinant mouse IL-2 (20 ng/ml; BioLegend, catalog no. 575404) was added to the cells as well as DMSO (Corning Lifescience Cellgro, catalog no. MT 25-950-CQC) or one of the following hydroxylase inhibitors (dissolved in DMSO): DMOG (Cayman Chemical, catalog no. 71210), molidustat (Selleck Chemicals, catalog no. S8138), daprodustat (Selleck Chemicals, catalog no. S8171), or roxadustat (Selleck Chemicals, catalog no. S1007).
Techniques: Quantitative RT-PCR, Two Tailed Test